Huang Kuan-Hsun, Hao Lei, Smith Philip B, Rogers Connie J, Patterson Andrew D, Ross A Catharine
Department of Nutritional Sciences.
Metabolomics Facility.
J Nutr. 2017 May;147(5):746-753. doi: 10.3945/jn.116.245951. Epub 2017 Mar 15.
The use of parenteral nutrition formulas is often associated with the development of hepatic steatosis. We have shown previously that the addition of a lipid emulsion (LE) rich in n-6 (ω-6) fatty acids (FAs) ameliorated triglyceride (TG) accumulation in the livers of nonobese mice fed a high-carbohydrate diet (HCD) for 5 wk. However, it remains unclear how rapidly this condition develops and whether it can be prevented by LE with or without a running wheel for voluntary exercise (Exe). We investigated in an 8-d study whether mice develop steatosis and whether the administration of LE with or without Exe reduces the concentration of total FAs and prevents an increase in the expression of genes in the liver associated with lipogenesis. Male C57BL/6 mice aged 5 wk were randomized into 5 groups: standard feed pellet (SFP); a liquid HCD (77% of total energy from carbohydrates and 0.5% from fat); HCD + Exe; HCD + 13.5% LE (67% carbohydrates and 13.5% fat); or HCD + 13.5% LE + Exe. Hepatic TG concentration, lipogenic genes, and total FAs were measured on day 8. Oil Red O staining and TG quantification showed hepatic TG accumulation on day 8; the addition of 13.5% LE either with or without Exe suppressed the TG accumulation compared with HCD ( < 0.005). With the use of quantitative reverse transcriptase-polymerase chain reaction analysis, the expression concentrations of lipogenic genes [ATP-citrate lyase, acetyl coenzyme A carboxylase 1, FA synthase (), and stearoyl coenzyme A desaturase 1 ()] in the HCD + 13.5% LE group were 26-60% of HCD ( < 0.01) and 11-38% of HCD in the HCD + 13.5% LE + Exe group ( < 0.001), with interactions for and ( < 0.05). With the use of gas chromatography-mass spectrometry analysis, the HCD + 13.5% LE group had lower monounsaturated fatty acids (38.7% of HCD) but higher polyunsaturated fatty acids (164% of HCD) ( < 0.001). In short-term studies designed to resemble the early dynamic stage of the development of hepatic steatosis, the addition of 13.5% LE to a liquid HCD reduced hepatic lipogenesis. Exe exerted an independent protective effect and interacted with LE to further reduce the expression of .
肠外营养配方的使用常与肝脂肪变性的发生有关。我们之前已经表明,添加富含n-6(ω-6)脂肪酸(FAs)的脂质乳剂(LE)可改善高碳水化合物饮食(HCD)喂养5周的非肥胖小鼠肝脏中的甘油三酯(TG)蓄积。然而,目前尚不清楚这种情况发展得有多快,以及带或不带供自愿运动(Exe)的跑步轮的LE是否可以预防。我们在一项为期8天的研究中调查了小鼠是否会发生脂肪变性,以及给予LE(带或不带Exe)是否会降低总脂肪酸浓度并防止肝脏中与脂肪生成相关的基因表达增加。将5周龄的雄性C57BL/6小鼠随机分为5组:标准饲料颗粒(SFP);液体HCD(碳水化合物提供总能量的77%,脂肪提供0.5%);HCD + Exe;HCD + 13.5% LE(67%碳水化合物和13.5%脂肪);或HCD + 13.5% LE + Exe。在第8天测量肝脏TG浓度、脂肪生成基因和总脂肪酸。油红O染色和TG定量显示第8天肝脏有TG蓄积;与HCD组相比,添加13.5% LE(带或不带Exe)均抑制了TG蓄积(P < 0.005)。使用定量逆转录-聚合酶链反应分析,HCD + 13.5% LE组中脂肪生成基因[ATP-柠檬酸裂解酶、乙酰辅酶A羧化酶1、脂肪酸合酶(FAS)和硬脂酰辅酶A去饱和酶1(SCD1)]的表达浓度为HCD组的26% - 60%(P < 0.01),HCD + 13.5% LE + Exe组为HCD组的11% - 38%(P < 0.001),FAS和SCD1存在交互作用(P < 0.05)。使用气相色谱-质谱分析,HCD + 13.5% LE组的单不饱和脂肪酸含量较低(为HCD组的38.7%),但多不饱和脂肪酸含量较高(为HCD组的164%)(P < 0.001)。在旨在模拟肝脂肪变性发展早期动态阶段的短期研究中,向液体HCD中添加13.5% LE可减少肝脏脂肪生成。Exe发挥了独立的保护作用,并与LE相互作用进一步降低了FAS的表达。